Shopping Cart 0
Cart Subtotal
USD 0

Apollo Endosurgery Inc (APEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company's product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endo's products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To USD 110 Million 11

Merger 13

Lpath and Apollo Endosurgery Merges 13

Equity Offering 14

Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 14

Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 15

Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 16

Lpath Raises USD12.5 Million in Private Placement of Shares 18

Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To USD 20 Million 20

Lpath Files Registration Statement For Public Offering Of Securities For Up To USD 40 Million 21

Lpath Completes Public Offering Of Shares For USD 12 Million 22

Lpath Announces Public Offering Of Class A Common Stock For USD 9.3 Million 23

Asset Transactions 24

Pfizer Plans To Sell Certain Ohthalmology R&D Assets 24

Apollo Endosurgery Inc-Key Competitors 25

Apollo Endosurgery Inc-Key Employees 26

Apollo Endosurgery Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results 28

May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 30

Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 31

Oct 26, 2017: Apollo Endosurgery Reports Third Quarter 2017 Results 33

Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 35

Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 37

May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 38

Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 39

Corporate Communications 41

May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 41

Nov 16, 2017: David C. Pacitti Joins Apollo Endosurgery Board of Directors 42

Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 43

Government and Public Interest 44

Jun 25, 2018: Two diabetes medications don't slow progression of type 2 diabetes in youth 44

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To USD 110 Million 11

Lpath and Apollo Endosurgery Merges 13

Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 14

Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 15

Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 16

Lpath Raises USD12.5 Million in Private Placement of Shares 18

Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To USD 20 Million 20

Lpath Files Registration Statement For Public Offering Of Securities For Up To USD 40 Million 21

Lpath Completes Public Offering Of Shares For USD 12 Million 22

Lpath Announces Public Offering Of Class A Common Stock For USD 9.3 Million 23

Pfizer Plans To Sell Certain Ohthalmology R&D Assets 24

Apollo Endosurgery Inc, Key Competitors 25

Apollo Endosurgery Inc, Key Employees 26

Apollo Endosurgery Inc, Other Locations 27

Apollo Endosurgery Inc, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Apollo Endosurgery Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company's product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endo's products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To USD 110 Million 11

Merger 13

Lpath and Apollo Endosurgery Merges 13

Equity Offering 14

Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 14

Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 15

Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 16

Lpath Raises USD12.5 Million in Private Placement of Shares 18

Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To USD 20 Million 20

Lpath Files Registration Statement For Public Offering Of Securities For Up To USD 40 Million 21

Lpath Completes Public Offering Of Shares For USD 12 Million 22

Lpath Announces Public Offering Of Class A Common Stock For USD 9.3 Million 23

Asset Transactions 24

Pfizer Plans To Sell Certain Ohthalmology R&D Assets 24

Apollo Endosurgery Inc-Key Competitors 25

Apollo Endosurgery Inc-Key Employees 26

Apollo Endosurgery Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results 28

May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 30

Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 31

Oct 26, 2017: Apollo Endosurgery Reports Third Quarter 2017 Results 33

Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 35

Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 37

May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 38

Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 39

Corporate Communications 41

May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 41

Nov 16, 2017: David C. Pacitti Joins Apollo Endosurgery Board of Directors 42

Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 43

Government and Public Interest 44

Jun 25, 2018: Two diabetes medications don't slow progression of type 2 diabetes in youth 44

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apollo Endosurgery Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Apollo Endosurgery Inc, Medical Devices Deals, 2012 to YTD 2018 9

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To USD 110 Million 11

Lpath and Apollo Endosurgery Merges 13

Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 14

Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 15

Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 16

Lpath Raises USD12.5 Million in Private Placement of Shares 18

Lpath Files Registration Statement For Public Offering Of Class A Common Stock For Up To USD 20 Million 20

Lpath Files Registration Statement For Public Offering Of Securities For Up To USD 40 Million 21

Lpath Completes Public Offering Of Shares For USD 12 Million 22

Lpath Announces Public Offering Of Class A Common Stock For USD 9.3 Million 23

Pfizer Plans To Sell Certain Ohthalmology R&D Assets 24

Apollo Endosurgery Inc, Key Competitors 25

Apollo Endosurgery Inc, Key Employees 26

Apollo Endosurgery Inc, Other Locations 27

Apollo Endosurgery Inc, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Apollo Endosurgery Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.